Hemostatic alterations in fatty liver disease

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 4, 2010, Pages 325-327

  Kargili, Ayse ^a   Cipil, Handan ^b   Karakurt, Feridun ^a   Kasapoglu, Benan ^c   Koca, Cemile ^c   Aydn, Murat ^c   Uysal, Sema ^c   Ikizek, Mustafa ^c   Uz, Ebru ^d   Balcik, Ozlem Sahin ^b   Kosar, Ali ^b  

^a Division of Endocrinology   (Turkey)

^b Division of Hematology   (Turkey)

^c Department of Biochemistry ^*  (Turkey)

^d FATIH UNIVERSITY   (Turkey)

Author keywords

Factor 7; Factor 8; Homeostasis; Nonalcoholic fatty liver disease; Protein C; Protein S

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; GAMMA GLUTAMYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C; PROTEIN S;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMAN; MALE; NONALCOHOLIC FATTY LIVER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTHROMBIN TIME; THROMBOCYTE COUNT;

ADULT; BLOOD COAGULATION TESTS; FACTOR VII; FACTOR VIII; FATTY LIVER; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET COUNT; PROTEIN C; PROTEIN S;

EID: 77951922485     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328337b3f8     Document Type: Article

References (16)

1. Willner IR, Waters B, Patil SR, Reuben A, Morelli J, Riely CA. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 2001; 96: 2957-2961.
2. Bugianesi E, Leone N, Vanni E. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-140.
3. Bjö rnsson E. The clinical aspects of nonalcoholic fatty liver disease. Minerva Gastroenterol Dietol 2008; 54: 7-18.
4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
5. Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, et al., Coagulation in Liver Disease Group. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 2006; 44: 1039-1046.
6. O'Grady JG, Langley PG, Isola LM, Aledort LM, Williams R. Coagulopathy of fulminant hepatic failure. Semin Liver Dis 1986; 6: 159-163.
7. Mammen EF. Coagulation abnormalities in liver disease. Haemotol Oncol Clin North Am 1992; 6: 1247-1257.
8. Lisman T, Leebeek FWG, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol 2002; 37: 280-287.
9. Brown JB, Emerick KM, Brown DL, Whitington PF, Alonso EM. Recombinant factor 7a improves coagulopathy caused by liver failure. J Pediatr Gastroenterol Nutr 2003; 37: 268-272.
10. Kelly DA, Tuddenham EG. Haemostatic problems in liver disease. Gut 1986; 27: 339-349.
11. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of 'hypersplenic' thrombocytopenia. J Clin Invest 1966; 45: 645-657.
12. Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, et al. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut 1999; 44: 754-758.
13. Pereira J, Accatino L, Alfaro J, Brahm J, Hidalgo P, Mezzano D. Platelet autoantibodies in patients with chronic liver disease. Am J Hematol 1995; 50: 173-178.
14. Yoshikawa Y, Sakata Y, Toda G, Oka H. The acquired vitamin K dependent gamma-carboxylation deficiency in hepatocellular carcinoma involves not only prothrombin, but also protein C. Hepatology 1988; 8: 524-530.
15. Leebeek FWG, Kluft C, Knot EAR, de Maat MPM, Wilson JHP. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis. Gastroenterology 1991; 101: 1382-1390.
16. Pernambuco JR, Langley PG, Hughes RD, Izumi S, Williams R. Activation of the fibrinolytic system in patients with fulminant liver failure. Hepatology 1993; 18: 1350-1356.